Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging

Journal of Nuclear Medicine

Volumn 46, Issue 9, 2005, Pages 1537-1545

  Wang, Jing Hung ^a   Scollard, Deborah A ^b   Teng, Shirley ^a   Reilly, Raymond M ^a,b   Piquette Miller, Micheline ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

ATP binding cassette transporters; Inflammation; Multidrug resistance; Radiopharmaceuticals

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1A; MULTIDRUG RESISTANCE PROTEIN 1B; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; ESCHERICHIA COLI; FEMALE; IMAGING SYSTEM; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTIBODY SPECIFICITY; BREEDING; ENDOTOXEMIA; FETUS; METABOLIC CLEARANCE RATE; METABOLISM; PREGNANCY; PRENATAL DEVELOPMENT; SCINTISCANNING; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; ENDOTOXEMIA; FEMALE; FETUS; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; P-GLYCOPROTEIN; PREGNANCY; PREGNANCY, ANIMAL; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM TC 99M SESTAMIBI; TISSUE DISTRIBUTION;

EID: 27744517566     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Slaviero KA, Clarke SJ, Rivory LP. Inflammatory response: an unrecognized source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. 2003;4:224-232.
2. Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res. 1998;15:706-711.
3. Kalitsky-Szirtes J, Shayeganpour A, Brocks DR, Piquette-Miller M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab Dispos. 2003;30:845-852.
4. Goralski KB, Hartmann G, Piquette-Miller M, Renton KW. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol. 2003;139:35-48.
5. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation. 1990;82:1826-1838.
6. Piwnica-Worms D, Rao V, Kronauge J, Croop J. Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry. 1995;34:12210-12220.
7. Chen CC, Meadows B, Regis J, et al. Detection of in vivo P-glycoprotein inhibition by PSC-833 using Tc-99m sestamibi. Clin Cancer Res. 1997;4:545-552.
8. Peck RA, Hewett J, Harding MW, et al. Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin. J Clin Oncol. 2001;19:3130-3141.
9. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Kao CH. Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results. Cancer Lett. 2000;153:95-100.
10. Filipits M, Suchomel RW, Dekan G, et al. MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res. 1996;2:1231-1237.
11. Hendrikse NH, Franssen EJ, van der Graal WT, et al. Tc-99m-Sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer. 1998;77:353-358.
12. 99mTc-MIBI imaging in patients with lung cancer. J Nucl Med. 2001;42:1476-1483.
13. Sharma V, Luker G, Piwnica-Worms D. Molecular imaging of gene expression and protein function in vivo with PET and SPECT. J Magn Reson Imaging. 2002;16:336-351.
14. Maffioli L, Gasparini M, Chiti A, et al. Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur J Nucl Med. 1996;23:308-311.
15. Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol. 2001;1:189-199.
16. Hartmann G, Cheung A, Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther. 2002;303:273-281.
17. Warren G, Van Ess P, Watson A, Mattson M, Blouin R. Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response. J Interferon Cytokine Res. 2001;21:821-826.
18. Lee G, Piquette-Miller M. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol. 2001;79:876-884.
19. Kao CH, Tsai SC, Liu TJ, et al. P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Cancer Res. 2001;61:1412-1414.
20. 99mTc-tetrofosmin. Biochem Pharmacol. 2000;60:413-426.
21. O'Tuama LA, Treves ST, Larar JN, et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med. 1993;34:1045-1051.
22. Tomura N, Hirano H, Watanabe O, et al. Preliminary results with technetium-99m MIBI SPECT imaging in patients with brain tumors: correlation with histological and neuroradiological diagnoses and therapeutic response. Comput Med Imaging Graph. 1997;21:293-298.
23. Soler C, Beauchesne P, Maatougui K, et al. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med. 1998;25:1649-1657.24.
24. Ak I, Gulbas Z, Altinel F, Vardareli E. Tc-99m MIBI uptake and its relation to the proliferative potential of brain tumors. Clin Nucl Med. 2003;28:29-33.
25. 99mTc-sestamibi SPET? Eur J Nucl Med. 1998;25:401-409.
26. Meissner K, Sperker B, Karsten C, et al. Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy. J Histochem Cytochem. 2002;50:1351-1356.